Divi’s Laboratories and TVS Motor Company have emerged as potential candidates for inclusion in the Nifty 50 during the March 2027 index review, according to an assessment by independent research firm Quiddity Leaderboard. If the projected changes materialise, Divi’s Labs could replace Max Healthcare Institute, while TVS Motor could replace HDFC Life.
The potential reshuffle is significant because inclusion in the Nifty 50 can create forced buying from passive funds, exchange-traded funds and other products that track the benchmark. Quiddity estimates the possible changes could generate around $824 million in passive inflows, but the estimate and the proposed constituents remain subject to change because the reference period is still far from complete.
Key takeaways
- Divi’s Laboratories is currently viewed as the leading candidate to replace Max Healthcare in the Nifty 50.
- TVS Motor could replace HDFC Life if the current free-float market-cap rankings persist.
- The March 2027 review uses data from August 1, 2026, to January 31, 2027.
- Only 34% of the reference period had elapsed when the latest assessment was made.
- Quiddity estimates potential passive inflows of around $824 million from the proposed changes.
- TVS Motor and Divi’s Labs had also been among the next eligible stocks during the September 2026 review but did not meet the required threshold at that time.
- Divi’s Labs delivered 28% year-over-year revenue growth and 65.5% profit growth in Q1 FY27.
- TVS Motor reported 38% revenue growth and a 51% increase in profit in Q1 FY27.
- The possible inclusion is not yet an NSE decision and should not be treated as confirmed.
Why Divi’s Labs and TVS Motor are back in the Nifty 50 conversation
The latest development is partly a continuation of the September 2026 index review.
During that review, BSE Ltd replaced Wipro in the Nifty 50. TVS Motor and Divi’s Laboratories were the next two eligible companies by average free-float market capitalisation, but neither entered the index because the required market-capitalisation threshold was not met.
At that time, TVS Motor had a six-month average free-float market capitalisation of approximately ₹84,566 crore, while Divi’s Labs stood at about ₹82,930 crore.
NSE Indices said the two smallest remaining Nifty 50 constituents did not meet the required comparison threshold needed to facilitate those additions.
That situation could change by the March review.
The companies now have another six-month measurement period in which share prices, free-float market capitalisation and the relative rankings of existing Nifty constituents can change.
How the March 2027 review works
The Nifty 50 is not changed simply because a company’s market capitalisation rises above another company’s market capitalisation.
NSE Indices uses a defined methodology based primarily on average free-float market capitalisation, alongside other eligibility requirements.
Free-float market capitalisation refers to the market value of shares that are considered available for public trading rather than shares held by promoters, controlling shareholders and certain other strategic holders.
For the Nifty 50, an eligible non-member company generally needs an average free-float market capitalisation of at least 1.5 times that of the smallest constituent.
The index is reviewed twice a year, in March and September. The March review uses six months of data ending January 31, while the September review uses data ending July 31.
The changes become effective on the last trading day of March or September.
This methodology is important because it explains why a company can be one of the largest candidates outside the index but still fail to enter during a particular review.
The March reference period is still incomplete
The biggest reason investors should be cautious about treating the latest list as a prediction is that the reference period has only partially elapsed.
The March 2027 review covers August 1, 2026, through January 31, 2027.
According to Jeyakumar Janaghan of Quiddity Leaderboard, only about 34% of this period had been completed when the current assessment was made.
That leaves several months for stock prices and free-float market capitalisation rankings to change.
A large move in one of the candidate stocks could alter its ranking. Likewise, a rally or correction in an existing Nifty constituent could change the threshold required for inclusion.
Consequently, Divi’s Labs and TVS Motor should be described as potential or likely candidates, rather than confirmed additions.
The final decision will come from NSE Indices after completion of the review process.
Why Divi’s Labs is the leading candidate
Divi’s Laboratories appears to have the strongest case among the two candidates under the current assessment.
Quiddity expects a potential deletion of Max Healthcare from the Nifty 100 to automatically result in its removal from the Nifty 50. That would create an opening for the highest-ranked eligible replacement.
Divi’s Labs is currently identified as that leading replacement candidate.
The pharmaceutical company also has strong recent operating momentum.
For Q1 FY27, Divi’s Laboratories reported consolidated revenue from operations of approximately ₹3,080 crore, up 27.8% from ₹2,410 crore in the year-earlier quarter.
Consolidated net profit rose 65.5% to approximately ₹902 crore, compared with ₹545 crore a year earlier.
The combination of earnings growth and a large free-float market capitalisation has strengthened the company’s position in the index-selection rankings.
However, earnings performance alone does not guarantee inclusion. The Nifty methodology is based on eligibility and market-capitalisation criteria, meaning the stock must continue to meet the required thresholds when the reference period closes.
TVS Motor has a separate path into the index
TVS Motor’s potential entry is based on a different comparison.
According to Quiddity, the company’s average free-float market capitalisation is currently more than 1.5 times that of HDFC Life, which could make it eligible to replace the insurer if Max Healthcare is removed and the resulting rankings remain intact.
That would create two potential changes to the Nifty 50 rather than a single replacement.
TVS Motor also enters the review with strong operating momentum.
The company reported its highest-ever quarterly revenue of ₹13,896 crore in Q1 FY27, representing 38% year-over-year growth.
EBITDA rose 41% to ₹1,779 crore, while EBITDA margin improved to 12.8% from 12.5%.
Profit after tax increased 51% to ₹1,174 crore.
The company’s sales performance was also strong, with total two- and three-wheeler volumes rising 28% to 1.63 million units during the quarter.
Electric two-wheeler sales increased 86% to nearly 130,000 units.
These numbers do not determine index eligibility by themselves, but strong earnings and market performance can influence the market capitalisation ranking that ultimately matters for the review.
What happens to Max Healthcare?
Max Healthcare is the company most directly exposed to the potential reshuffle.
Under the current scenario, its potential deletion from the Nifty 100 would automatically result in its removal from the Nifty 50.
This is an important distinction.
The current report does not suggest that NSE has already decided to remove Max Healthcare. Instead, Quiddity’s analysis indicates that the healthcare company could fall out of the relevant ranking by the end of the reference period.
If that happens, index-tracking funds would need to reduce or eliminate their Nifty 50 exposure to the stock.
That can create selling pressure around the effective date, although the actual price impact depends on the amount of passive money tracking the index, existing market positioning and how investors anticipate the change.
HDFC Life could also face an index exit
HDFC Life is the second potential outgoing constituent.
Quiddity identifies TVS Motor as a possible replacement because TVS Motor’s average free-float market capitalisation is currently above the required 1.5-times threshold relative to HDFC Life.
Again, the outcome depends on where the respective companies rank when the six-month reference period ends.
This is why index-rebalance projections can change substantially before the official announcement.
The stock market can also anticipate the changes. Investors who expect a company to enter a major index may buy shares before the effective date, while traders may position for potential selling in stocks expected to leave.
Consequently, some of the eventual price impact can occur before the actual index change.
The potential $824 million flow
The estimated $824 million of potential inflows is one of the most important numbers attached to the latest assessment.
These are not new investments being announced by companies.
They represent potential passive fund flows associated with index rebalancing.
When a stock is added to the Nifty 50, funds that seek to replicate the index generally need to increase their holdings in that stock. At the same time, funds may need to reduce holdings in companies removed from the index.
The magnitude of these flows depends on the assets benchmarked to the index, the stock’s eventual weight and how closely individual funds track the benchmark.
Therefore, the $824 million figure should be viewed as an estimate rather than guaranteed buying.
Why index inclusion can matter beyond passive buying
Nifty 50 inclusion can have effects beyond the immediate rebalancing flows.
The index is one of India’s most widely followed equity benchmarks and is used for portfolio benchmarking, derivatives and index funds.
A company entering the index may receive greater attention from institutional investors and international funds that use benchmark membership as part of their investment framework.
Higher institutional participation can also improve liquidity.
There can be a perception benefit as well. Membership in the Nifty 50 places a company among India’s most prominent large-cap listed businesses and can increase its visibility among investors.
However, index inclusion does not change a company’s underlying earnings or business economics.
A stock can receive passive inflows following inclusion and still underperform later if its fundamentals deteriorate.
The reverse effect for potential deletions
The same mechanism works in the opposite direction.
If Max Healthcare and HDFC Life leave the Nifty 50, passive funds tracking the index may have to reduce their holdings.
That can create temporary selling pressure.
But an index deletion does not necessarily mean that a company has become fundamentally weaker.
Index membership is determined by a combination of market capitalisation, free float and eligibility criteria. A company can leave because other businesses have grown faster rather than because its own business has deteriorated.
This distinction is especially important when interpreting the potential removal of HDFC Life and Max Healthcare.
Five potential changes in the Nifty 100
The possible Nifty 50 changes are part of a broader potential reshuffle.
Quiddity expects the Nifty 100 to see the maximum permitted five changes in the March review.
Potential additions include:
- Life Insurance Corporation of India
- ICICI Prudential Asset Management
- BHEL
- Lenskart
- Groww
Potential deletions include:
- Vedanta
- Mazagon Dock Shipbuilders
- Godrej Consumer Products
- Ambuja Cements
- Max Healthcare
These are also projections rather than confirmed NSE decisions.
The broader list shows how rapidly India’s market-capitalisation rankings can change as newer listed companies grow and existing constituents move up or down the rankings.
Why the September review matters
The previous review provides useful context for understanding the current candidates.
BSE entered the Nifty 50 effective September 30, replacing Wipro.
The selection demonstrated the importance of the free-float market-capitalisation threshold. BSE’s six-month average free-float market capitalisation was about ₹1.41 lakh crore, more than 1.5 times Wipro’s approximately ₹55,930 crore.
TVS Motor and Divi’s Labs ranked next among eligible candidates but did not qualify because the smallest remaining constituents did not satisfy the necessary threshold relationship.
The March review could therefore represent the next stage of the same competitive process.
What could change before January 31?
Several factors could disrupt the current projection.
The first is share-price performance.
Because average free-float market capitalisation is used, a sustained rise or decline in any candidate or existing constituent can change the rankings.
The second is corporate actions.
Changes in share capital or free-float levels can influence the market-capitalisation calculations used for index selection.
The third is eligibility.
Companies must satisfy the relevant trading and market requirements. Changes in derivatives eligibility, trading characteristics or corporate structure can affect selection.
The fourth is competition.
Other companies outside the current projected list could rise sufficiently during the remaining reference period to challenge the current candidates.
That is why the present assessment should be treated as a snapshot rather than a final forecast.
What investors should watch
The most important date for investors tracking the possible reshuffle is January 31, 2027, when the reference period for the March review ends.
Between now and then, investors should watch:
- Six-month average free-float market capitalisation
- Relative ranking against existing Nifty 50 constituents
- Trading and F&O eligibility
- Corporate actions affecting free float
- Quarterly earnings and share-price performance
- Any official NSE Indices announcement
For Divi’s Labs and TVS Motor, continued market-capitalisation strength is the most important factor behind the current inclusion thesis.
For Max Healthcare and HDFC Life, the key question is whether they remain above the relevant ranking and eligibility thresholds.
The Bigger Picture
The potential March 2027 Nifty reshuffle highlights how India’s benchmark index is gradually reflecting the changing composition of the country’s largest listed businesses. Divi’s Labs represents the growing weight of high-value pharmaceutical and contract-manufacturing businesses, while TVS Motor reflects the increasing scale of India’s two-wheeler and electric-mobility industry.
But investors should not mistake a research projection for an official index decision. With only 34% of the reference period completed, the rankings can still change materially before January 31. The eventual impact will depend on where the companies stand when NSE Indices completes its formal review.
Looking Ahead
Divi’s Labs and TVS Motor will remain stocks to watch as the March 2027 review progresses, particularly because both already came close to qualifying during the September reshuffle. Their recent operating performance gives the inclusion case additional support, but market-capitalisation rankings—not earnings growth alone—will determine eligibility.
If the current scenario survives until the end of the reference period, the changes could create meaningful passive flows into the incoming stocks and out of the potential deletions. The next few months will therefore be less about the headline announcement and more about whether Divi’s Labs and TVS Motor can maintain their relative free-float market-capitalisation advantage.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
